Momenta Pharm

MNTA NASDAQ
10.00
+0.25
+2.56%
After Hours: 10.00 0 -0.01% 16:18 07/23 EDT
Open
9.78
Prev Close
9.75
High
10.09
Low
9.58
Volume
377.63K
Avg Vol (3M)
471.57K
52 Week High
32.20
52 Week Low
9.51
% Turnover
0.38%
Market Cap
986.12M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Momenta Pharm MNTA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. The Company has developed generic version of LOVENOX (enoxaparin sodium injection) and COPAXONE (glatiramer acetate injection). GLATOPA 20 milligrams (mg)/ milliliters (mL) is a generic version of once-daily COPAXONE 20 mg/mL indicated for the treatment of patients with relapsing forms of multiple sclerosis, a chronic disease of the central nervous system characterized by inflammation and neurodegeneration. COPAXONE is available in both a once-daily 20 mg/mL formulation and a three-times-weekly 40 mg/mL formulation. The Company's Enoxaparin Sodium Injection is a generic version of LOVENOX indicated for the prevention and treatment of deep vein thrombosis and to support the treatment of acute coronary syndromes. The Company's programs include M254, M281 (Anti-FcRn candidate) and M230.
MORE >

Recently

Name
Price
%Change